[SuperSliv.biz] Меркола. Клетка на диете. Клетка на диете. Научноеоткрытие о влиянии жиров
 Скачать 2.31 Mb.
|
|
Глава 1 1. N. Lane, Power, Sex, Suicide: Mitochondria and the Meaning of Life (New York: Oxford University Press, 2006), 3. 2. Там же. 3. Там же, location 5926. 4. “Our Best Days Are Yours,” Kellogg’s, https://www.kelloggs.com/en_US/who-we-are/our- history.html, accessed 12/2/16. 5. L. B. Wrenn, Cinderella of the New South (Knoxville, TN: University of Tennessee Press, 1995), 84. 6. T. G. Graham and D. Ramsey, The Happiness Diet (New York: Rodale Books, 2012), 25. 7. F. G. Mather, “Waste Products: Cotton-Seed Oil,” Popular Science Monthly, May 1894, 104. 8. Graham and Ramsey, The Happiness Diet. “Our Heritage,” Crisco, http://www.crisco.com/ about_crisco/history.aspx, accessed 12/2/16. 9. S. Gokhale, “Marketing Crisco,” Weston A. Price Foundation, June 25, 2013, http:// www.westonaprice.org/health-topics/marketing-crisco/, accessed 12/2/16. 10. Graham and Ramsey, The Happiness Diet. T. L. Blasbalg et al., “Changes in Consumption of Omega-3 and Omega-6 Fatty Acids in the United States During the 20th Century,” American Journal of Clinical Nutrition , 93, no. 5 (May 2011): 950–962: DOI: 10.3945/ajcn.110.006643. Epub 2011 Mar 2. 11. S. F. Halabi, Food and Drug Regulation in an Era of Globalized Markets (Cambridge, MA: Academic Press, 2015), 148. 12. T. Neltner, M. Maffini, “Generally Recognized as Secret: Chemicals Added to Food in the United States,” National Resources Defense Council, April 2014, https://www.nrdc.org/sites/default/ files/safety-loophole-for-chemicals-in-food-report.pdf, accessed 12/2/16. 13. R. J. de Souza et al., “Intake of Saturated and Trans Unsaturated Fatty Acids and Risk of All Cause Mortality, Cardiovascular Disease, and Type 2 Diabetes: Systematic Review and Meta- analysis of Observational Studies,” BMJ (2015): 351, DOI: 10.1136/bmj.h3978. 14. V. T. Samuel, K. F. Petersen, and G. I. Shulman, “Lipid-induced Insulin Resistance: Unraveling the Mechanism,” Lancet, 375 (2010): 2267–2277, DOI: 10.1016/ S0140-6736(10)60408-4. 15. K. Kavanagh et al., “Trans Fat Diet Induces Abdominal Obesity and Changes in Insulin Sensitivity in Monkeys,” Obesity, 15, no. 7 (July 2007): 1675–1684, DOI: 10.1038/oby.2007.200. 16. M. C. Morris et al., “Dietary fats and the risk of incident Alzheimer’s disease,” Archives of Neurology , 60, no. 2 (2003): 194–200, DOI: 10.1001/archneur.60.2.194. 17. C. M. Benbrook, “Impacts of Genetically Engineered Crops on Pesticide Use in the U.S. – the First Sixteen Years,” Environmental Sciences Europe, 24, no. 1 (2012): 24, DOI: 10.1186/2190-4715-24-24. 18. N. Defarge et al., “Co-Formulants in Glyphosate-Based Herbicides Disrupt Aromatase Activity in Human Cells below Toxic Levels,” International Journal of Environmental Research and Public Health , 13, no. 3 (2016): 264, DOI: 10.3390/ijerph13030264. 19. A. Keys, “Mediterranean Diet and Public Health: Personal Reflections,” American Journal of Clinical Nutrition, 61, no. 6 supplement (1995): 1321S–1323S. 20. A. Keys, “Atherosclerosis: A Problem in Newer Public Health,” Journal of Mt. Sinai Hospital , New York, 20, no. 2 (July–August 1953): 134. 21. N. Teichholz, The Big Fat Surprise (New York: Simon & Schuster, 2014), 32–33. Д. Меркола. «Клетка «на диете». Научное открытие о влиянии жиров на мышление, физическую активность и обмен веществ» 221 22. Central Committee for Medical and Community Program of the American Heart Association, “Dietary Fat and Its Relation to Heart Attacks and Strokes,” Circulation 23 (1961): 133– 136. http://circ.ahajournals.org/content/circulationaha/23/1/133.full.pdf, accessed 12/2/16. 23. H. M. Marvin, 1924–1964: The 40 Year War on Heart Disease (New York: American Heart Association, 1964). 24. A. Keys, “Coronary Heart Disease in Seven Countries,” Circulation, 41, no. 1 (1970): 1186– 1195. 25. Dietary Guidelines Advisory Committee, “History of the Dietary Guidelines for Americans,” Nutrition and Health: Dietary Guidelines for Americans, 2005, U.S. Department of Health and Human Services, https://health.gov/dietaryguidelines/dga2005/report/ html/G5_History.htm, accessed 12/2/16. 26. Z. Harcombe et al., “Evidence from Randomised Controlled Trials Did Not Support the Introduction of Dietary Fat Guidelines in 1977 and 1983: A Systematic Review and Meta-analysis,” Open Heart , 2, no. 1 (2015): DOI: 10.1136/openhrt-2014-000196. 27. U.S. Department of Health and Human Services and U.S. Department of Agriculture, “Key Recommendations: Components of Healthy Eating Patterns,” 2015–2020 Dietary Guidelines for Americans, 8th Edition (December 2015): 15, https://health.gov/dietaryguidelines/2015/guidelines/ chapter-1/key-recommendations/#footnote-4, accessed 12/2/16. 28. Centers for Disease Control and Prevention, Division of Diabetes Translation, “Long-term Trends in Diabetes,” (2016), https://www.cdc.gov/diabetes/statistics/slides/long_term_trends.pdf. 29. C. D. Fryar, M. Carroll, and C. Ogden, Division of Health and Nutrition Examination Surveys, “Prevalence of Overweight, Obesity, and Extreme Obesity Among Adults Aged 20 and Over: United States, 1960–1962 Through 2013–2014,” table 1, Centers for Disease Control and Prevention, http://www.cdc.gov/nchs/data/hestat/obesity_adult_13_14/ obesity_adult_13_14.htm#Figure, accessed 12/2/16. 30. N. Howlader et al. (eds.), “SEER Cancer Statistics Review, 1975–2013.” 31. “SEER Stat Fact Sheets: Cancer of Any Site,” National Cancer Institute, http:// seer.cancer.gov/statfacts/html/all.html, accessed November 28, 2016. 32. P. A. Heidenreich et al., “Forecasting the Future of Cardiovascular Disease in the United States,” Circulation, 123, no. 8 (2011): 933–944, DOI: 10.1161/CIR.0b013e31820a55f5. 33. P. Leren, “The Effect of Plasma-Cholesterol-Lowering Diet in Male Survivors of Myocardial Infarction: A Controlled Clinical Trial,” Bulletin of the New York Academy of Medicine, 44, no. 8 (1968): 1012–1020. 34. S. Dayton et al., “A Controlled Clinical Trial of a Diet High in Unsaturated Fat in Preventing Complications of Atherosclerosis,” Circulation, 40 (1969): II-1-II-63, DOI: 10.1161/01.CIR.40.1S2.II-1. 35. I. D. Frantz et al., “Test of effect of lipid lowering by diet on cardiovascular risk. The Minnesota Coronary Survey,” Arteriosclerosis, 9, no. 1 (January–February 1989): 129–135, DOI: 10.1161/01.ATV.9.1.129. 36. O. Turpeinen et al., “Dietary Prevention of Coronary Heart Disease: The Finnish Mental Hospital Study,” International Journal of Epidemiology, 9, no. 2 (1979): 99–118, DOI: 10.1093/ ije/8.2.99. 37. “Controlled Trial of Soya-Bean Oil in Myocardial Infarction,” The Lancet, 292, no. 7570 (1968): 693–700, DOI: 10.1016/S0140-6736(68)90746-0. 38. “Multiple Risk Factor Intervention Trial Group: Public Annual Report, Multiple Risk Factor Intervention Trial, June 30, 1975 to July 1, 1976,” Journal of the American Medical Association , 248, no. 12 (1982): 1465–1477, https://clinicaltrials.gov/ct2/show/NCT00000487, accessed 12/2/16. Д. Меркола. «Клетка «на диете». Научное открытие о влиянии жиров на мышление, физическую активность и обмен веществ» 222 39. P. W. Siri-Tarino et al., “Meta-analysis of Prospective Cohort Studies Evaluating the Association of Saturated Fat with Cardiovascular Disease,” American Journal of Clinical Nutrition , 91, no. 3 (2010): 535–546, DOI: 10.3945/ajcn.2009.27725. 40. R. Chowdhury et al., “Association of Dietary, Circulating, and Supplement Fatty Acids With Coronary Risk: A Systematic Review and Meta-analysis,” Annals of Internal Medicine, 160 (2014): 398–406, DOI, 10.7326/M13-1788. 41. De Souza et al., “Intake of Saturated and Trans Unsaturated Fatty Acids and Risk of ll Cause Mortality, Cardiovascular Disease, and Type 2 Diabetes.” 42. C. E. Ramsden et al., “Use of Dietary Linoleic Acid for Secondary Prevention of Coronary Heart Disease and Death: Evaluation of Recovered Data From the Sydney Diet Heart Study and Updated Meta-analysis,” BMJ, 346 (2013): DOI: 0.1136/bmj.e8707. 43. Там же. 44. M. A. Austin et al., “Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction,” Journal of the American Medical Association, 260, no. 13 (1988): 1917–1921, DOI: 10.1001/jama.1988.03410130125037. 45. D. M. Dreon et al., “Change in Dietary Saturated Fat Intake Is Correlated with Change in Mass of Large Low-Density-Lipoprotein Particles in Men,” American Journal of Clinical Nutrition, 67, no. 5 (1998): 828–836, accessed 12/2/16. 46. K. Gunnars, “Saturated Fat, Good or Bad?” Authority Nutrition, https:// authoritynutrition.com/saturated-fat-good-or-bad/, accessed 12/2/16. 47. P. W. Siri-Tarino et al., “Saturated Fat, Carbohydrate, and Cardiovascular Disease,” American Journal of Clinical Nutrition , 91, no. 3 (2010): 502–509, DOI: 10.3945/ajcn.2008.26285. Д. Меркола. «Клетка «на диете». Научное открытие о влиянии жиров на мышление, физическую активность и обмен веществ» 223 Глава 2 1. L. Cordain, “The Nutritional Characteristics of a Contemporary Diet Based Upon Paleolithic Food Groups,” Journal of the American Nutraceutical Association, 5, no. 5 (2002): 15–24. 2. J. J. Meidenbauer, P. Mukherjee, and T. N. Seyfried, “The Glucose Ketone Index Calculator: A Simple Tool to Monitor Therapeutic Efficacy for Metabolic Management of Brain Cancer,” Nutrition & Metabolism , vol. 12 (2015): 12. DOI: 10.1186/s12986-015-0009-2. 3. R. Agrawal and F. Gomez-Pinilla, “‘Metabolic Syndrome’ in the Brain: Deficiency in Omega-3 Fatty Acid Exacerbates Dysfunctions in Insulin Receptor Signalling and Cognition,” The Journal of Physiology , 590, no. 10 (2012): 2485, DOI: 10.1113/jphysiol.2012.230078. 4. J. R. Ifland et al., “Refined Food Addiction: A Classic Substance Use Disorder,” Medical Hypotheses , 72, no. 5 (May 2009): 518–526, DOI: 10.1016/j.mehy.2008.11.035. 5. T. R. Nansel et al., “Greater Food Reward Sensitivity Is Associated with More Frequent Intake of Discretionary Foods in a Nationally Representative Sample of Young Adults,” Frontiers in Nutrition , 3, no. 33, 8/18/2016, DOI: 10.3389/fnut.2016.00033. 6. S. D. Phinney and J. S. Volek, The Art and Science of Low-Carbohydrate Living (Miami, FL: Beyond Obesity LLC, 2011), 10. 7. G. D. Maurer, et al., “Differential Utilization of Ketone Bodies by Neurons and Glioma Cell Lines: a Rationale for Ketogenic Diet as Experimental Glioma Therapy,” BMC Cancer 11 (2011): 315, DOI: 10.1186/1471-2407-11-315. 8. R. Sender, S. Fuchs, and R. Milo, “Revised Estimates for the Number of Human and Bacteria Cells in the Body,” PLoS Biology, 14, no. 8 (2016): e1002533, DOI: 10.1371/journal.pbio.1002533. 9. R. Rosedale, “Life, Death, Food and the Disease of Aging,” presented at the American Academy of Anti-Aging in Orlando, Florida, 2011. 10. C. E. Forsythe et al., “Comparison of Low Fat and Low Carbohydrate Diets on Circulation Fatty Acid Composition and Markers of Inflammation,” Lipids, 43, no. 1 (2008): 65–77, DOI: 10.1007/s11745-007-3132-7. 11. S. McKenzie, “Yoshinori Ohsumi Wins Nobel Prize for Medical Research on Cells,” CNN.com, October 3, 2016, http://www.cnn.com/2016/10/03/health/nobel-prize-2016-physiology- medicine-yoshinori-ohsumi/, accessed 12/2/16. 12. K. J. Bough et al., “Mitochondrial Biogenesis in the Anticonvulsant Mechanism of the Ketogenic Diet,” Annals of Neurology, 60 (2006): 223–235, DOI: 10.1002/ana.20899. 13. P. J. Cox, K. Clarke, “Acute Nutritional Ketosis: Implications for Exercise Performance and Metabolism,” Extreme Physiology & Medicine, 3 (2014): 1, DOI: 10.1186/2046-7648-3-17. 14. O. E. Owen et al., “Liver and Kidney Metabolism During Prolonged Starvation,” Journal of Clinical Investigation , 48, no. 3 (1969): 574–583. 15. M. Akram, “A Focused Review of the Role of Ketone Bodies in Health and Disease,” Journal of Medicinal Food , 16, no. 11 (November 2013): 965–967, DOI: 10.1089/jmf.2012.2592. 16. Там же. 17. Phinney and Volek, The Art and Science of Low-Carbohydrate Living, 10. 18. Interview with Jeff Volek, Ph.D., http://articles.mercola.com/sites/articles/ archive/2016/01/31/high-fat-low-carb-diet-benefits.aspx, accessed 12/2/16. 19. J. C. Newman and E. Verdin, “β-hydroxybutyrate: Much More Than a Metabolite,” Diabetes Research and Clinical Practice , 106, no. 2 (2014): 173–181, DOI: 10.1016/ j.diabres.2014.08.009. 20. A. Paoli et al., “Ketogenic Diet in Neuromuscular and Neurodegenerative Diseases,” BioMed Research International , 2014 (2014), DOI: 10.1155/2014/474296. Д. Меркола. «Клетка «на диете». Научное открытие о влиянии жиров на мышление, физическую активность и обмен веществ» 224 21. M. A. McNally and A. L. Hartman, “Ketone Bodies in Epilepsy,” Journal of Neurochemistry , 121, no. 1 (2012): 28–35, DOI: 10.1111/j.1471–4159.2012.07670.x. 22. J. Moore, Keto Clarity (Victory Belt Publishing, 2014), 58. 23. A. J. Brown, “Low-Carb Diets, Fasting and Euphoria: Is There a Link between Ketosis and Gamma-hydroxybutyrate (GHB)?” Medical Hypotheses, 68, no. 2 (2007): 268–271, DOI: 10.1016/ j.mehy.2006.07.043. Д. Меркола. «Клетка «на диете». Научное открытие о влиянии жиров на мышление, физическую активность и обмен веществ» 225 Глава 3 1. E. L. Knight et al., “The Impact of Protein Intake on Renal Function Decline in Women with Normal Renal Function or Mild Renal Insufficiency,” Annals of Internal Medicine, 138. no. 6 (2003): 460–467, DOI: 10.7326/0003-4819-138-6-200303180-00009. 2. M. I. Frisard et al., “Effect of 6-Month Calorie Restriction on Biomarkers of Longevity, Metabolic Adaptation, and Oxidative Stress in Overweight Individuals: A Randomized Controlled Trial,” http://jamanetwork.com/journals/jama/fullarticle/1108368. 3. M. E. Levine et al., “Low Protein Intake Is Associated with a Major Reduction in IGF-1, Cancer, and Overall Mortality in the 65 and Younger but Not Older Population,” Cell Metabolism, 19, no. 3 (2014): 407–417, DOI: 10.1016/j.cmet.2014.02.006. 4. J. Guevara-Aguirre et al., “Growth Hormone Receptor Deficiency Is Associated With a Major Reduction in Pro-aging Signaling, Cancer and Diabetes in Humans,” Science Translational Medicine , 3, no. 70 (2011): 70, DOI: 10.1126/scitranslmed.3001845. 5. S. I. A. Apelo and D. W. Lamming, “Rapamycin: An InhibiTOR of Aging Emerges From the Soil of Easter Island,” Journal of Gerontology, 71, no. 7 (2016): 841–849, DOI: 10.1093/gerona/ glw090. 6. S. M. Solon-Biet et al., “The Ratio of Macronutrients, Not Caloric Intake, Dictates Cardiometabolic Health, Aging, and Longevity in Ad Libitum-Fed Mice,” Cell Metabolism, 19, no. 3 (2014): 418–430, DOI: 10.1016/j.cmet.2014.02.009. Д. Меркола. «Клетка «на диете». Научное открытие о влиянии жиров на мышление, физическую активность и обмен веществ» 226 Глава 4 1. “Ferritin: The Test,” American Association for Clinical Chemistry, https:// labtestsonline.org/understanding/analytes/ferritin/tab/test/, accessed May 9, 2016. 2. E. D. Weinberg, “The Hazards of Iron Loading,” Metallomics, 2, no. 11 (November, 2010): 732–740, DOI: 10.1039/c0mt00023j. 3. M. D. Beaton and P. C. Adams, “Treatment of Hyperferritinemia,” Annals of Hepatology, 11, no. 3 (2012): 294–300, PMID: 22481446. 4. G. Ortiz-Estrada et al., “Iron-Saturated Lactoferrin and Pathogenic Protozoa: Could This Protein Be an Iron Source for Their Parasitic Style of Life?” Future Microbiology, 7, no. 1 (2012): 149–164, DOI: 10.2217/fmb.11.140. 5. D. J. Fleming et al., “Dietary Factors Associated with the Risk of High Iron Stores in the Elderly Framingham Heart Study Cohort,” American Journal of Clinical Nutrition, 76, no. 6 (2002): 1375–1384, PMID: 12450906. 6. T. Iwasaki et al., “Serum Ferritin Is Associated with Visceral Fat Area and Subcutaneous Fat Area,” Diabetes Care, 28, no. 10 (2005): 2486–2491, PMID: 16186284. 7. S. K. Park et al., “Association between Serum Ferritin Levels and the Incidence of Obesity in Korean Men: A Prospective Cohort Study,” Endocrine Journal, 61, no. 3 (2014): 215–224, DOI: 10.1507/endocrj.EJ13-0173. 8. Там же. 9. J. M. Fernandez-Real et al., “Serum Ferritin as a Component of the Insulin Resistance Syndrome,” Diabetes Care, 21, no. 1 (1998): 62–68, DOI: 10.2337/diacare.21.1.62. 10. J. Montonen et al., “Body Iron Stores and Risk of Type 2 Diabetes: Results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study,” Diabetologia , 55, no. 10 (2012): 2613–2621, DOI: 10.1007/s00125-012-2633-y. 11. J. M. Fernandez-Real, A. Lopez-Bermejo, and W. Ricart, “Iron Stores, Blood Donation, and Insulin Sensitivity and Secretion,” Clinical Chemistry, 51, no. 7 (June 2005): 1201–1205, DOI: 10.1373/clinchem.2004.046847. 12. B. J. Van Lenten et al., “Lipid-Induced Changes in Intracellular Iron Homeostasis in Vitro and in Vivo,” Journal of Clinical Investigation, 95, no. 5 (1995): 2104–2110, DOI: 10.1172/ JCI117898. 13. N. Stadler, R. A. Lindner, and M. J. Davies, “Direct Detection and Quantification of Transition Metal Ions in Human Atherosclerotic Plaques: Evidence for the Presence of Elevated Levels of Iron and Copper,” Arteriosclerosis, Thrombosis, and Vascular Biology, 24 (2004): 949–954, DOI: 10.1161/01.ATV.0000124892.90999.cb. 14. W. B. Kannel et al., “Menopause and Risk of Cardiovascular Disease: The Framingham Study,” Annals of Internal Medicine, 85 (1976): 447–452, DOI: 10.7326/0003-4819-85-4-447. 15. M. A. Lovell et al., “Copper, Iron and Zinc in Alzheimer’s Disease Senile Plaques,” Journal of the Neurological Sciences , 158, no. 1 (June 11, 1998): 47–52, DOI: 10.1016/ S0022-510X(98)00092-6. 16. K. Jellinger et al., “Brain Iron and Ferritin in Parkinson’s and Alzheimer’s diseases,” Journal of Neural Transmission , 2 (1990): 327, DOI: 10.1007/BF02252926. 17. G. Bartzokis et al., “Brain Ferritin Iron as a Risk Factor for Age at Onset in Neurodegenerative Diseases,” Annals of the New York Academy of Sciences, 1012 (2004): 224– 236, DOI: 10.1196/annals.1306.019. 18. S. Ayton et al., “Ferritin Levels in the Cerebrospinal Fluid Predict Alzheimer’s Disease Outcomes and Are Regulated by APOE,” Nature Communications, 6 (2015): 6760, DOI: 10.1038/ ncomms7760. Д. Меркола. «Клетка «на диете». Научное открытие о влиянии жиров на мышление, физическую активность и обмен веществ» 227 19. W. Z. Zhu et al., “Quantitative MR Phase-Corrected Imaging to Investigate Increased Brain Iron Deposition of Patients with Alzheimer’s Disease,” Radiology, 253 (2009): 497–504, DOI: 10.1148/radiol.2532082324. 20. A. A. Alkhateeb and J. R. Connor, “The Significance of Ferritin in Cancer: Anti-Oxidation, Inflammation and Tumorigenesis,” Biochimica et Biophysica Acta, 1836, no. 2 (Dec 2013): 245–254, DOI: 10.1016/j.bbcan.2013.07.002. 21. J. I. Wurzelmann et al., “Iron Intake and the Risk of Colorectal Cancer,” Cancer Epidemiology, Biomarkers and Prevention , 5, no. 7 (July 1, 1996): 503–507. PMID: 8827353. 22. Y. Deugnier, “Iron and Liver Cancer,” Alcohol, 30, no. 2 (2003): 145–150. 23. L. R. Zacharski et al., “Decreased Cancer Risk after Iron Reduction in Patients with Peripheral Arterial Disease: Results from a Randomized Trial,” JNCI: Journal of National Cancer Institute , 100, no. 14 (2008): 996–1002, DOI: 10.1093/jnci/djn209. 24. L. Valenti et al., “Association between Iron Overload and Osteoporosis in Patients with Hereditary Hemochromatosis,” Osteoporosis International, 20, no. 4 (April, 2009): 549–555, DOI: 10.1007/s00198-008-0701-4. 25. “Hemochromatosis,” National Institute of Diabetes and Digestive and Kidney Disease (2016), http://www.niddk.nih.gov/health-information/health-topics/liver-disease/hemochromatosis/ Pages/facts.aspx, accessed May 9, 2016. 26. “Welcome,” Iron Disorders Institute (2016), http://www.hemochromatosis.org/ #symptoms, accessed May 9, 2016. 27. “Serum Iron Test,” MedlinePlus Medical Encyclopedia (2016), https://www.nlm.nih.gov/ medlineplus/ency/article/003488.htm, accessed May 9, 2016. 28. “TIBC, UIBC, and Transferrin Test: Iron Binding Capacity; IBC; Serum Iron Binding Capacity; Siderophilin; Total Iron Binding Capacity; Unsaturated Iron Binding Capacity,” Lab Tests Online (2016), https://labtestsonline.org/understanding/analytes/tibc/tab/test/, accessed May 9, 2016. 29. L. Zacharski, “Ferrotoxic Disease: The Next Great Public Health Challenge,” Clinical Chemistry , 60, no. 11 (November 2014): 1362–1364, DOI: 10.1373/clinchem.2014.231266. 30. P. Mangan, Dumping Iron: How to Ditch This Secret Killer and Reclaim Your Health, Phalanx Press, 2016, locations 308–312. 31. Там же, locations 1353–1356. 32. Там же, locations 1609–1612. 33. Там же, locations 416–418. 34. Там же, locations 428–431. 35. Там же, locations 582–595. |